Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - XBiotech Inc. | f10q_052715.htm |
| EX-32.2 - EXHIBIT 32.2 - XBiotech Inc. | exh_322.htm |
| EX-31.2 - EXHIBIT 31.2 - XBiotech Inc. | exh_312.htm |
| EX-31.1 - EXHIBIT 31.1 - XBiotech Inc. | exh_311.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of XBiotech Inc. (the “Company”) on Form 10-K for the period ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Simard, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/JOHN SIMARD
John Simard
Chief Executive Officer and President
(Principal Executive Officer)
May 27, 2015
This certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.